TACE is the preferred treatment for unresectable liver cancer, however the procedure inevitably causes ischemia and hypoxia in the tumor and surrounding liver tissue (15), leading to hepatocyte damage and transient increases in blood ALT levels. The gene discussed is GPT; the disease is neoplasm.